New
We are thrilled to announce the second Revolutionizing Vitiligo (ReV) Conference, scheduled for Sunday, December 10, 2023. This virtual, CME-accredited conference is dedicated to vitiligo, focusing on diagnosis, treatment, and management.
AGENDA
- 8:30 AM Opening Remarks/Comments. NANETTE SILVERBERG, MD, MPHC, FAAD, FAAP
- 8:40 AM Early Intervention Yields Best Results. NANETTE SILVERBERG, MD, MPHC, FAAD, FAAP
- 9:00 AM Measuring Stigma in Vitiligo: Lessons from My Quality-of-Life Work. KHALED EZZEDINE, MD, PHD
- 9:20 AM Overcoming Stigma in Vitiligo: My Experiences in India. RASHMI SARKAR, MD, MNAMS
- 9:40 AM. What We Learned About Stigma from the “Big” Study. AMY PALLER, MD
- 10:00 AM Recommendations on Testing from the Pediatric, Adolescent, and Young Adult Guidelines Group. LESLIE CASTELO-SOCIO, MD
- 10:20 AM Recommendations on Topical Care from the Pediatric, Adolescent, and Young Adult Guidelines Group. NANETTE SILVERBERG, MD, MPHC, FAAD, FAAP
- 10:40 AM The Pipeline: How Developing Medications Address Unmet Needs. KHALED EZZEDINE, MD, PHD
- 11:00 AM The JAK Inhibitors: Currently Available and The Pipeline. DAVID ROSMARIN, MD
- 11:30 AM Q&A ALL FACULTY
- 11:50 AM Vitiligo is Associated with New Onset Osteoporosis: A Population-Based Study. NAAMA COHEN
- 11:58 AM Prognostic Factors in Pediatric Patients with Vitiligo. MARTHA ALEJANDRA MORALES-SÁNCHEZ, MD, PHD
- 12:06 PM Case Series of Topical 1.5% Ruxolitinib Cream for Pediatric Vitiligo. HARRY M. MEISTER
- 12:14 PM Use of AI in Patient Education (video). YAN VALLE
- 12:24 PM Closing Remarks. NANETTE SILVERBERG, MD, MPHC, FAAD, FAAP
Organized by: Foundation for Dermatology Education, established in 2020 by Professor Jonathan I. Silverberg and devoted to educating dermatologists, allergists, pediatricians/pediatric dermatologists and other specialists, as well as primary care clinicians, nurse practitioners, physician assistants, nurses, other allied health professionals and patients about skin disease and its management.
Registration is Now Open! Join us for an enlightening journey into vitiligo care and management.
For more info and registration, please visit: ReV Virtual Conference 2023
For inquiries, contact Patrice Melluso: patrice@revolutionizingad.com
FAQOther Questions
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticoster...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
The tropical fern Polypodium leucotomos (also known as Polypodium aureum) and its relative Polypodium decumanumhave shown potential benefits for managing vitiligo and other auto...
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.